OR WAIT null SECS
October 01, 2006
This article provides an overview of functionality, functionality-related characteristics, and excipients performance.
Facing cost pressures and regulatory changes, pharmaceutical companies address the need for increased functionality by looking to excipients.
September 02, 2006
The Product Quality Research Institute (PQRI) conducted an open, publicly available, electronic survey of current excipient-control strategies among pharmaceutical excipient manufacturers, excipient distributors, and drug-product manufacturers (excipient users). Among the major findings are:
Potent-compound awareness training for operators is important to understand why the containment and controls are in place.
The debate over functionality is not about to be settled anytime soon.
August 02, 2006
Combinatorial catalysis in asymmetric synthesis and asymmetric biaryl Suzuki coupling highlight recent advances in chiral chemistry. Plus the marriage of green and chiral chemistry.
July 02, 2006
Select large custom manufacturers expand capacity, private equity firms buy companies in transition, and players from India and China build their positions.
June 02, 2006
CMOs account for 20–30% of biopharm production. Big Pharma also is filling the biologics supply chain.
May 02, 2006
Indian suppliers of active pharmaceutical ingredients and dosage formulations expand in India, the United States, and Europe.
April 02, 2006
New biocatalytic and chemocatalytic routes to chiral intermediates and developments in simulated-moving-bed and supercritical-fluid chromatography for resolving racemic mixtures.